Latest Andain Inc (ANDN) Headlines Andain Inc
Post# of 7
Posted On: 03/08/2014 8:11:23 PM
Latest Andain Inc (ANDN) Headlines
Andain Inc. Announces 2,000 Units Initial Production of the Breakthrough Miniature Disposable Insulin Pump for Use in Clinical Trials for Type-I and Type-II Diabetes
PR Newswire - Mon Jun 10, 8:30AM CDT
Andain Inc. (OTCBB: ANDN) ("Andain"), a company engaged in commercializing novel technologies in the fields of biotech, medical and life sciences through its accelerating incubator program, announced today the production of 2,000 miniature disposable insulin pump units for clinical trials.
Andain Inc. Discusses and Provides Update on Its Breakthrough Wrinkle Treating Nano-Particles Booster and Delivery for Regenerating Skin Tissue
PR Newswire - Thu May 16, 8:30AM CDT
Andain Inc. (OTCBB: ANDN) ("Andain" or the "Company"), a company engaged in commercializing novel technologies in biotech, medical and life sciences fields through its incubator program, today discussed and provided an update on its breakthrough, innovative peptide booster and delivery nano-particles for wrinkle treating and regenerating skin tissue collagen.
Andain Inc reports breakthrough 510K miniature disposable insulin pump
M2 - Thu Apr 11, 9:46AM CDT
Biotec novel technologies company Andain Inc (OTCQB:ANDN) said on Wednesday that it has successfully completed all of the required tests for the 510K regulation of its innovative miniature disposable insulin pump.
Andain Inc. Announces Successful 510K Tests of its Breakthrough Miniature Disposable Insulin Pump
PR Newswire - Wed Apr 10, 8:00AM CDT
Andain Inc. (OTCQB: ANDN) ("Andain"), a company engaged in commercializing novel technologies in biotech, medical and life sciences fields through its accelerating incubator program, announces today of the successful 510K tests of its miniature disposable insulin pump.
Andain Inc. Discusses and Provides Update on its Breakthrough Stem Cell Therapy for the Treatment and Regeneration of Severely Damaged Muscle Tissue
PR Newswire - Tue Apr 02, 8:00AM CDT
Andain Inc. (OTCQB: ANDN) ("Andain" or the "Company"), a company engaged in commercializing novel technologies in biotech, medical and life sciences fields through its incubator program, today discussed and provided an update on its breakthrough, innovative stem cell therapy for treating and regenerating severely damaged muscle tissue.
Andain Inc. Announces 2,000 Units Initial Production of the Breakthrough Miniature Disposable Insulin Pump for Use in Clinical Trials for Type-I and Type-II Diabetes
PR Newswire - Mon Jun 10, 8:30AM CDT
Andain Inc. (OTCBB: ANDN) ("Andain"), a company engaged in commercializing novel technologies in the fields of biotech, medical and life sciences through its accelerating incubator program, announced today the production of 2,000 miniature disposable insulin pump units for clinical trials.
Andain Inc. Discusses and Provides Update on Its Breakthrough Wrinkle Treating Nano-Particles Booster and Delivery for Regenerating Skin Tissue
PR Newswire - Thu May 16, 8:30AM CDT
Andain Inc. (OTCBB: ANDN) ("Andain" or the "Company"), a company engaged in commercializing novel technologies in biotech, medical and life sciences fields through its incubator program, today discussed and provided an update on its breakthrough, innovative peptide booster and delivery nano-particles for wrinkle treating and regenerating skin tissue collagen.
Andain Inc reports breakthrough 510K miniature disposable insulin pump
M2 - Thu Apr 11, 9:46AM CDT
Biotec novel technologies company Andain Inc (OTCQB:ANDN) said on Wednesday that it has successfully completed all of the required tests for the 510K regulation of its innovative miniature disposable insulin pump.
Andain Inc. Announces Successful 510K Tests of its Breakthrough Miniature Disposable Insulin Pump
PR Newswire - Wed Apr 10, 8:00AM CDT
Andain Inc. (OTCQB: ANDN) ("Andain"), a company engaged in commercializing novel technologies in biotech, medical and life sciences fields through its accelerating incubator program, announces today of the successful 510K tests of its miniature disposable insulin pump.
Andain Inc. Discusses and Provides Update on its Breakthrough Stem Cell Therapy for the Treatment and Regeneration of Severely Damaged Muscle Tissue
PR Newswire - Tue Apr 02, 8:00AM CDT
Andain Inc. (OTCQB: ANDN) ("Andain" or the "Company"), a company engaged in commercializing novel technologies in biotech, medical and life sciences fields through its incubator program, today discussed and provided an update on its breakthrough, innovative stem cell therapy for treating and regenerating severely damaged muscle tissue.
(0)
(0)